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Abstract
Background: The Australian Synchrotron Imaging and Medical Beamline (IMBL) was designed as the world’s widest
synchrotron X-ray beam, enabling both clinical imaging and therapeutic applications for humans as well as the
imaging of large animal models. Our group is developing methods for imaging the airways of newly developed CF
animal models that display human-like lung disease, such as the CF pig, and we expect that the IMBL can be
utilised to image airways in animals of this size.
Methods: This study utilised samples of excised tracheal tissue to assess the feasibility, logistics and protocols
required for airway imaging in large animal models such as pigs and sheep at the IMBL. We designed an image
processing algorithm to automatically track and quantify the tracheal mucociliary transport (MCT) behaviour of
103 μm diameter high refractive index (HRI) glass bead marker particles deposited onto the surface of freshly-
excised normal sheep and pig tracheae, and assessed the effects of airway rehydrating aerosols.
Results: We successfully accessed and used scavenged tracheal tissue, identified the minimum bead size that is
visible using our chosen imaging setup, verified that MCT could be visualised, and that our automated tracking
algorithm could quantify particle motion. The imaging sequences show particles propelled by cilia, against gravity,
up the airway surface, within a well-defined range of clearance speeds and with examples of ‘clumping’ behaviour
that is consistent with the in vivo capture and mucus-driven transport of particles.
Conclusion: This study demonstrated that the wide beam at the IMBL is suitable for imaging MCT in ex vivo tissue
samples. We are now transitioning to in vivo imaging of MCT in live pigs, utilising higher X-ray energies and shorter
exposures to minimise motion blur.
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Background
Cystic fibrosis (CF) lung disease is caused by an improp-
erly functioning ion channel in the airway epithelium
and results in a reduction in the depth of the airway
surface liquid (ASL) layer and impaired mucociliary
transport (MCT). MCT is the mechanism by which tiny
hair-like structures called cilia move inhaled particles
along the airway surfaces and out of the lungs. In CF,
the airway dehydration and production of thick sticky
mucus result in a cycle of inflammation and infection
that ultimately leads to progressive lung disease and
early death from lung failure [1].
We have developed an airway gene transfer technique
that inserts the corrective gene (CFTR) into defective
airway cells of CFTR-null mice, with the resulting CFTR
ion-channel correction lasting for at least 12 months [2].
Although we can electrically measure the ionic changes
produced by our gene therapy using the established trans-
epithelial potential difference measurement technique,
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there are currently no methods to rapidly and accurately
quantify small corrections in the dysfunctional mucocili-
ary activity or any improvements in airway health in a live
animal, after a potential treatment is performed. The abil-
ity to detect beneficial effects produced by novel therapies
in live CF airways soon after treatment would substantially
advance research into new genetic and pharmaceutical CF
treatments.
MCT has typically been quantified by measuring the
bulk clearance of radioactive or fluorescent particles
deposited in the airways [3]. To rapidly determine the
efficacy of genetic and pharmaceutical therapies for CF
we have developed MCT monitoring methods in live
anaesthetised normal and CFTR-null mice to measure
the transport rate and behaviour of individual deposited
10-30 μm diameter high refractive index (HRI) glass
bead marker particles using propagation-based synchro-
tron phase contrast X-ray imaging (PCXI) [4]. Compared
to conventional sources, a synchrotron can produce X-
rays that are much brighter, more spatially coherent and
closer to monochromatic, enabling PCXI setups able to
utilise X-ray refraction (in addition to absorption) to
achieve high spatial and temporal resolution, and excel-
lent airway and lung soft tissue contrast. Nuclear
imaging techniques, fluoroscopy and CT imaging
systems are not able to resolve particles of this size.
These synchrotron X-ray MCT imaging methods have
been developed in mice over more than 8 years at the
SPring-8 synchrotron in Japan, and we have recently
begun to transition them to the Imaging and Medical
Beamline (IMBL) at the Australian Synchrotron [5].
However, CFTR-null mice are a limited model because
they do not exhibit human-like lung pathophysiology
[6], and although the nasal airways of these mice do
exhibit the CF pathophysiology, there is evidence that
nasal MCT is not altered in CFTR-null mice [4, 7].
Furthermore, since it is designed for large animal im-
aging, the IMBL beam characteristics are not well suited
to resolving the 10–30 μm particles normally used for
MCT measurement in a ~1 mm diameter mouse airway.
Our group is interested in using newly developed
large-animal CF animal models, such as the CF pig,
which display human-like lung disease and have human-
sized lungs [8]. In future imaging experiments we plan
to test the effectiveness of our gene therapy treatment in
live CF animals at the IMBL, to rapidly and non-
invasively determine the effectiveness of our gene
therapy protocols via assessment of MCT-rate changes.
The IMBL is primarily designed for performing
propagation-based PCXI due to its high x-ray flux and
high coherence, partly brought about by a large source-
to-sample distance (greater than 137 m in the satellite
building hutch). The beamline setup produces an X-ray
beam of up to 400 mm × 40 mm (W × H) at the sample
position, making the imaging of larger animals such as
sheep, pigs, and potentially humans, possible in the
future.
A recent article has detailed the importance and feasi-
bility of MCT analyses for CF, and revealed the differ-
ences between CF and normal airways, both at baseline
and under pharmaceutical manipulation [9]. That study
used a standard human clinical CT setup combined with
large (350 μm diameter x 25 μm thickness) tantalum
discs as MCT markers that were insufflated into the air-
ways using a puff of air. CT scans were acquired every
15 s for 10 minutes to track micro-disc motion, and
used a minimum detection velocity of 1 mm/min. They
showed that a similar proportion of micro-discs cleared
the CF and non-CF airways over the 10-minute period,
and that in both groups the discs migrated toward the
ventral tracheal surface. Impaired clearance in the CF
group was only apparent when a methacholine challenge
was applied to both. Importantly, they noted that MCT
assays could be used to report therapeutic efficacy.
The aim of the present study was to report the feasi-
bility of using PCXI at the IMBL to quantify MCT in
excised normal large animal airways using HRI glass
marker particles. We used freshly excised normal
tracheal tissue from sheep and pigs to remove the im-
aging complexity that would be produced by surround-
ing body tissues. We aimed to use our ex vivo imaging
system to determine the range of MCT rates, whether
there are preferential patterns of MCT flow within the
trachea, and to demonstrate the effect of common clin-
ical rehydrating therapies for CF airways that are known
to alter MCT [10]. Importantly, we aimed to obtain the
baseline MCT data from normal large animal trachea as
well as permit the establishment of the necessary logis-
tics and IMBL needs and protocols for airway MCT
imaging. This study was essential for our continued
efforts to establish imaging and technical infrastructure
required for the transition to in vivo trials in large ani-
mal models such as normal and CF pigs, in order to val-
idate the effects of genetic and pharmaceutical therapies.
Methods
The Imaging and Medical Beamline at the Australian
Synchrotron was used for all imaging experiments, and
the data was collected over two beamtime allocations.
Beamline setup
The storage ring operated at 3 GeV and a ring current of
200 mA for both experiments. The RMS electron beam
size in the straight sections was 320 × 16 μm [11], and
corresponded to a Gaussian FWHM of 754 × 38 μm in
the horizontal and vertical directions, respectively. The
IMBL X-ray beam was produced by a superconducting
multi-pole wiggler functioning at a field strength of
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3.0 T. The required energy of 30 keV was selected using
a dual silicon Laue crystal monochromator, and the
source-to-monochromator distance was 16.15 m.
All imaging was performed in the IMBL satellite build-
ing experimental hutch 3B at a distance of ~136 m from
the storage ring [12], using the previously established
setup shown in Murrie et al. [13]. A sample to detector
distance of 2.5 m was used, and images with an effective
pixel size of 16 μm (field of view of ~ 16.6 mm × 14 mm)
were captured using the Ruby detector [14]. This was the
smallest field of view of which the detector was capable,
and was selected in order to visualise most of the width of
the ~15–20 mm diameter tracheae at high magnification.
X-ray beam uniformity is to a certain extent governed
by the power load on the monochromator. For the first
experiment the power of the input spectrum was reduced
using copper filters, resulting in a lower flux and uniform
illumination. Exposure times of 1 s were required to use
most of the dynamic range (16-bits) of the PCO.edge sen-
sor (PCO imaging, Germany). In the second experiment
the copper filters were removed, increasing the available
flux and enabling an exposure length of 250 ms to be
used, at the expense of a slight degradation in the quality
of the beam shape.
MCT tracking particle testing
Prior to the excised tissue experiments, the visibility of a
selection of differently-sized HRI glass beads (Corpuscu-
lar, NY, USA) was assessed using the chosen imaging
parameters. Minute quantities of HRI beads with diame-
ters of 52, 78 and 103 μm were placed on Kapton tape
and imaged.
Excised tissue preparation
The first experiment utilised five freshly-excised normal
adult sheep tracheae and the second utilised three
freshly-excised normal adult pig tracheae (Camborough
29, ~250 kg female); all samples were recovered from
animals off-site from the synchrotron. Animals were se-
dated and then humanely killed by sodium pentobarbital
overdose, with the trachea rapidly excised immediately
after death. Care was taken to minimise the amount of
blood that entered the tracheae. After excision each tra-
chea was washed in a solution of 20 mM Krebs-HEPES
Buffer at pH 7.4, and stored for transport to the IMBL
in a fresh container of the same buffer solution at ~4 °C.
At the IMBL each trachea was cut into ~20 mm long
segments (typically resulting in 3–5 segments per
trachea, containing ~3 cartilage rings each, with each
segment slightly taller than the imaging field of view).
Prior to imaging, the tracheal segment was pinned out
vertically onto the base of a custom-made polycarbonate
trachea chamber on well-moistened gauze, then slowly
warmed to and maintained at physiological temperature
(~37 °C). The segments were normally mounted with
the cranial end at the top, so that the predominant
direction of MCT was upwards, against gravity. In the
sheep experiment two segments were mounted “upside
down” to verify that MCT occurred in the expected
direction (downwards in this “upside down” case). In the
pig experiment four segments of conducting airway
tissue from, at and below the carina were also examined.
Samples were typically imaged within 8 h of excision
except for one during the sheep experiment that was de-
liberately imaged ~24 h after excision to assess whether
residual MCT activity was present after a prolonged
period in buffer at 4 °C.
Imaging
Each tracheal segment was placed on the hutch X-Y
stage with temperature maintained at ~37 °C, and ori-
ented such that images were captured from the dorsal/
ventral (anterior/posterior) direction. In the pig studies
images of the trachea were captured prior to HRI par-
ticle delivery, to be used for background subtraction. A
small quantity of 103 μm diameter HRI glass particles
were then delivered to the caudal end of the tracheal
segment using a mouse Dry Powder Insufflator™ (Penn-
Century, PA). For the sheep studies the particles were
placed on the ventral tracheal surface (i.e. the side op-
posite the trachealis muscle and oesophagus where
MCT was expected to be maximal [9]), and for the pig
studies on the dorsal tracheal surface (to detect any dor-
sal to ventral particle motion).
Ten minutes of baseline imaging was performed. For
some samples aerosolised 7% hypertonic saline, 0.9%
isotonic saline, or 9% mannitol were delivered to the
tracheal segment using an Aeroneb vibrating mesh
nebuliser (Aerogen, Ireland) inserted into the top of the
chamber, to test the effects of treatments known to alter
airway surface hydration. Aerosol was delivered for 30 s
at 50% duty cycle (equivalent to 15 s total aerosol gener-
ation, and ~50 μl liquid). Post-treatment imaging contin-
ued for 10 min to evaluate the duration of active MCT
clearance mechanisms against the same sample baseline,
and control tracheal samples. An example of a tracheal
segment prepared for imaging is shown in Fig. 1.
Hoegger et al. showed that deposited particles prefer-
entially migrated to the ventral tracheal surface [9, 15],
so to test whether this effect was detectable in our sam-
ples some segments were rotated axially 90° after the
first imaging run was completed. An additional sample
of beads was deposited in the same manner, but this
time onto the lateral tracheal wall. A second imaging
run, including aerosol delivery, was then performed in a
lateral direction to compare the MCT and spatial pattern
of particle movement beginning on a ventral or a lateral
wall of the trachea.
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Post-experimental analyses
Custom image analysis software (written by MD and de-
scribed in Appendix A) was used to measure and compare
particle MCT rates by identifying particles and tracking
their motion throughout the image sequences.
To validate the automated tracking algorithm the first
frame of each imaging run was manually analysed to
count the number of features incorrectly identified as
particles (false positives) and the number of moving
particles that were not correctly identified or tracked
(false negatives). These values were used along with the
number of detected particles (positives) to determine the
sensitivity of the algorithm.
Where appropriate, statistical analyses were performed
using GraphPad Prism 7. Data were tested for normality,
statistical significance was set at p = 0.05 and power =
0.80, and a one-way ANOVA and Bonferroni post-hoc
test were used for multiple comparisons. MCT rates are
presented as mean plus standard deviation.
Results
At the chosen magnification all three bead sizes were
visible on the Kapton tape (see Fig. 2). However, to en-
sure the beads were visible and could be reliably tracked
in the excised tissue segments, and in future live animal
studies where overlying tissue and respiratory motion
typically complicates image analysis, the 103 μm sized
beads were chosen.
A breakdown of the number of samples in each group
is shown in Table 1.
The MCT particle tracking algorithm was able to suc-
cessfully detect and track particle motion in all of the
sheep tracheal segments. An example of the tracked par-
ticles is shown in Fig. 3 and Additional file 1: Video S1
and Additional file 2: Video S2. Data from three of the
pig tracheal segments (Baseline + Iso, Baseline +Manni-
tol, and Lateral Baseline) was excluded due to tissue mo-
tion over the imaging period that made the background
subtraction algorithm (described in Appendix A1.2) fail.
A total of 1.37 million particles (average 35,035 per im-
aging run, or 234 per frame) and 3.8 million particles
(average 73,089 per imaging run, or 122 per frame) were
detected and tracked by the algorithm for the sheep and
pig experiments, respectively. The sensitivity was 96% in
the sheep experiment and 87% in the pig experiment.
Particle identification was more challenging in the pig
tracheal segments than the sheep segments because the
pig cartilage rings were much denser (and therefore
more strongly absorbing at the chosen energy of 30 keV)
Fig. 1 Tracheal imaging setup. a A pig tracheal segment in the ex vivo
sample chamber. The segment is pinned to a wax base using 25 Ga
syringe needles to prevent movement. The Aeroneb nebuliser is shown
inserted into the top of the sample chamber, and was used to deliver
aerosolised isotonic or hypertonic saline to the tissue. A temperature
and humidity sensor is visible on the left side of the container. The
entire chamber was maintained at 37 °C, but relied on passive
humidification from the wet gauze in the chamber. The same setup
was used for imaging the sheep tracheal segments. b The tracheal
tissue orientation, with imaging (x-ray beam) directions corresponding
to those used in Figs. 3 and 4
Fig. 2 X-ray images of differently-sized MCT tracking particles. Images of (a) 52 μm, (b) 78 μm and (c) 103 μm HRI glass beads on Kapton tape,
taken at 30 keV with the field of view set to ~ 16.6 mm x 14 mm to image the full width of the tracheal segments. The contrast is primarily due
to absorption. The insets show a 4x magnification of the beads. The brightness and contrast of the three images have been altered in the same
way to improve particle visualisation for publication and allow visual comparisons. The 103 μm beads were chosen for the ex vivo experiments.
Scale bar 2 mm
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as well as more textured (at times having features of a
similar appearance to the MCT tracking particles), and
there was little clear space between the cartilage rings
(see Fig. 3). However, apart from in the excluded image
sequences in which the segments moved during the
imaging period, there were few false positives at the
particle identification step. When false positives did
occur they were often caused by bubbles on the airway
surface. These were not present in many tracheal seg-
ments, but there were some in the airway from deeper
in the lung (see Additional file 3: Video S3). Due to their
infrequent occurrence relative to the true positives, and
the fact that they did not move substantially during
tracking, these false positives did not skew the results.
When particles aggregated very closely the particle
detection step (described in Appendix A) was unable to
accurately separate them into individual particles (pro-
ducing false negatives). Accordingly, when beads were
isolated they were more accurately identified and tracked
than when aggregated into groups. This happened more
frequently in the pig tracheal segments, but again had
little effect on the results because all particles in the
Table 1 The number of imaging runs in which MCT tracking
particles were successfully tracked in each group
Imaging direction Treatment Sheep (n = 5) Pigs (n = 3)








Other Upside down 2 0
At 24 h 1 0
Lung 0 4
39 51
Note that multiple runs (i.e. baseline followed by aerosol treatment) were
performed in some segments
Fig. 3 MCT tracking particles in sheep and pig tracheae. Example high magnification images of tracked 103 μm HRI glass MCT marker particles in
segments of excised sheep trachea (a and b) and pig trachea (c and d), from a dorsal/ventral view (a and c) and lateral view (b and d). For the
lateral images, the dorsal tracheal surface is to the left and the ventral tracheal surface to the right. The particles successfully detected and
tracked by our automated algorithm are marked with blue dots. The differences in cartilage texture and density between the sheep and pigs are
clearly visible. In panel (c) the edges of the plastic hubs of two syringe needles used to pin the segment in place can be seen on the left and the
right side of the image. Additional file 1: Video S1 and Additional file 2: Video S2 correspond to panels (a) and (c), respectively. Scale bar 2 mm
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aggregates normally moved at similar speed. Often parti-
cles were not tracked for the entire image sequence, with
the algorithm occasionally losing a particle for a frame
or two before detecting it again in subsequent frames. In
the sheep experiment there were some beads that moved
too fast to be accurately detected by the tracking code
(described in Appendix A1.4). Since we used a 15 pixel
maximum displacement to ensure tracking was successful,
particles moving faster than 6 mm/min could not be
tracked by this algorithm (see Additional file 1: Video S1).
This may have reduced the measured mean MCT rate in
the sheep experiment, and was one of the primary reasons
we increased the frame rate for the second (pig trachea)
experiment. For the pig tracheal segments the theoretical
maximum MCT rate that could be measured by the track-
ing algorithm was 24 mm/min.
Particle MCT was visible in all tracheal segments
examined, including the sheep segment that was deliber-
ately stored in chilled buffer solution for ~24 h after
excision. In the normally-prepared (caudal end upwards)
samples beads moved in the direction of preferential
MCT, primarily up the tracheal wall when oriented
against gravity, although interestingly they rarely moved
directly up the trachea at an angle of zero degrees. In
the two sheep tracheal segments that were mounted
“upside down” MCT also proceeded downwards, as
expected. Beads tended to organise and aggregate into
long strings, and appeared to move in favoured MCT
tracts. In the pig samples the beads typically moved cir-
cumferentially towards the ventral tracheal surface.
The mean instantaneous baseline MCT rate was 1.62 ±
1.22 mm/min for the sheep, and 1.32 ± 1.19 mm/min for
the pigs. Following treatment with aerosolised hypertonic
saline the average MCT rate over the 10-min period rose
to 2.50 ± 1.19 mm/min for the sheep, and 1.75 ± 1.59 mm/
min for the pigs; clearly individual rates would have been
higher at some time points. For the sheep tracheal segment
imaged upside down the instantaneous MCT rate was
1.45 ± 0.81 mm/min, and for the segment imaged 24 h
after excision the MCT rate was 0.34 ± .0.3 mm/min. In all
cases the measured mean MCT rates were lower than
those previously reported in humans; 5.7 ± 2.6 mm/min
[16] and 4.1 mm/min [16, 17] as well as in sheep; 8.2 ±
1.9 mm/min [18] live pigs; 6.9 ± 0.7 mm/min [15] and ex-
cised pig trachea; 2.3 ± 0.3 mm/min [19]. Although we did
see many particles moving at similar rates to these, the
presence of large numbers of very slow moving particles
lowered the average rate. From our pilot SPring-8 studies
in mice we suspect that the choice of MCT tracking parti-
cles (size and surface characteristics) may also play a role
in the particle transport rate, and may also be responsible
for some of the difference in our reported MCT rates.
The change in MCT rate in response to treatment
over the 10-min imaging period is shown in Fig. 4. The
data are clearer for the lateral view, and shows a transi-
ent increase in MCT rate following aerosol delivery that
Fig. 4 Response of pig and sheep MCT rate to treatment. Average MCT rate over time in response to treatment in (a) sheep dorsal/ventral, (b)
sheep lateral, (c) pigs dorsal/ventral, and (d) pigs lateral (**p < 0.01, ***p < 0.001, ANOVA vs baseline, mean + SD, n = 3)
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rapidly returned towards normal. This effect was not
statistically significant, likely because of the small num-
ber of aerosol treated segments, particularly in the sheep
experiment, as well as the wide variability in the MCT
rate of the individual beads.
To examine MCT directionality the magnitude and
direction of the instantaneous velocity of each tracked
particle was plotted on a two-dimensional heat-map (See
examples in Figs. 5 and 6). For the baseline runs (data not
shown) the hotspot remains close to the origin as the bulk
of the particles are moving slowly. Note that the t = 0
image corresponds with the first 15 s of aerosol delivery,
so some particles have already begun to move faster than
at baseline, also suggesting that the aerosol begins to act
very rapidly on some particles. The MCT rate of many
particles transiently increases with treatment, but returns
toward normal at the later time points.
For one of the pigs we also excised tissue from deeper
within the lung, including the carina, and verified that
particle transport could be tracked there in the same
manner (See Fig. 7 and Additional file 3: Video S3).
Discussion
The predominant direction of MCT appeared different be-
tween species, being along the length of the trachea in the
sheep, and more circumferentially in the pigs (see
Additional file 1: Video S1 and Additional file 2: Video S2).
This may have been because in the sheep the particles were
deposited on the ventral wall – the portion of the trachea
that Hoegger et al. showed particles migrate towards [9, 15]
– whereas in the pigs the particles were deposited on the
dorsal wall, and therefore had a more axial motion to
transport towards the ventral wall (See Additional file 1:
Video S1 and Additional file 2: Video S2). Further studies
must be performed to confirm this speculation.
At SPring-8, we have exploited synchrotron PCXI on a
highly coherent source (BL20XU and BL20B2) for live
small-animal imaging (mice and rats) where high flux is
critical to obtain very short exposure times (<50 ms) to
avoid motion blurring in animals with high respiratory
rates. High spatial coherence is necessary for PCXI,
however the experiments we describe here, with a larger
field of view and strong absorption contrast from the
beads, demonstrate that the reduced spatial coherence at
the Australian Synchrotron’s IMBL is sufficient for our
methods, making these experiments in large airways
viable at the IMBL. We expect that when imaging a
~20 kg piglet (i.e. 8–9 weeks old) the additional neck
tissue surrounding the trachea will require the use of a
higher energy (e.g. 60 keV) with an exposure time of
around 100 ms to maintain motion-free images during
respiration. However, based on the results from this
study, we predict that in vivo MCT measurements in a
live pig trachea are feasible.
These clear pilot data has shown the exciting potential
of the IMBL for performing live large animal imaging
when relevant large normal and CF animal models are
appropriate and available. These studies did have a num-
ber of limitations, including the rudimentary mainten-
ance of humidification (closed imaging vessel held at
37 °C) and the variability in the time between excision
and imaging for each segment. There was also an
Fig. 5 Lateral heat-map for MCT behaviour in sheep trachea. Two dimensional heat-map showing the effect of aerosolised hypertonic on the predominant
MCT particle velocity across the three relevant sheep tracheal segments (n= 2 sheep) over the 10-minute imaging period. The heat-map orientation is the
same as Fig. 3b and d; the dorsal tracheal surface is to the left and the ventral tracheal surface to the right. Stationary particles are at the origin, slow
moving particles are close to the axis origin, and faster moving particles are further away, with the angular position representing their direction of motion.
Red indicates more particles than yellow or blue. The heat maps indicate that the bulk of the particle motion is in a cranial direction, with a bias towards
the dorsal tracheal surface (the average angle of particle transport was -14.3° from vertical)
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absence of reciprocating airflow within the tracheal seg-
ment that would mimic the normal lung airflow condi-
tions during breathing; such airflow conditions are
known to release airway nucleotides that can influence
ASL depth and MCT rate [20]. However, these experi-
ments were designed as ex vivo studies using scavenged
tracheal tissue, to trial expected imaging, biological, and
logistical parameters with sufficient experimental flexi-
bility to enable imaging optimisation without the com-
plications of strict radiation dose control and live-animal
handling restrictions. Provided physiological support is
utilised to maintain adequate tissue hydration and
temperature, it would be possible to use this ex vivo
setup to image multiple particles in various locations
within large animal airway segments over long time
periods (e.g. multiple hours), and to examine the effects
of mucus reducing agents or other pharmaceuticals on
MCT function.
When extended to in vivo tracheal imaging using
higher X-ray energies for improved penetrating power
(and minimise the effects of overlying tissue and cartil-
age) we expect to be able to track multiple small
particles, perform repeat imaging, and image for long
periods; a protocol that will be useful for studying the ef-
fects of long-acting pharmaceuticals or genetic therapies
on MCT. Although imaging of the deeper airway was
possible in this study, we expect that in live imaging
experiments the greater lung motion in the deeper lung
regions would make accurate measurements in this
region much more challenging. The primary benefits of
using this type of two-dimensional imaging setup com-
pared to CT (e.g. as used by Hoegger et al. [9, 15]) is
that it can be used to track treatment effects for long
periods with reduced radiation exposure, it can track
multiple individual particles with high spatial and
temporal resolution and thereby examine clearance
heterogeneity and particulate grouping behaviour within
the trachea. This may be particularly informative in CF
models where some portions of the airway have dysfunc-
tional clearance while other areas retain essentially
normal clearance [21]. Future in vivo studies will deal
with essential aspects of in vivo experimental design,
and with reductions in radiation dose we expect that
repeated-measures studies that allow for the tracking of
Fig. 6 Dorsal/ventral heat-map for MCT behaviour in pig trachea. Two dimensional heat-map showing the effect of aerosolised hypertonic on MCT particle
velocity in the seven pig tracheal segments (n= 3 pigs) over the 10-minute imaging period. The heat-map orientation is the same as Fig. 3a and c. With
treatment the hot spot shifts slightly right, indicating that the bulk of the particle movement is laterally towards the right lateral wall (the average angle of
particle transport was +28.3° from vertical)
Fig. 7 Particle tracking at the pig carina. Particles could also be
successfully tracked at the pig carina. In this sample the presence of the
bubbles on the airway surface increased the false positive detection
rate. Additional file 3: Video S3 shows the tracking results for this
sample. Scale bar 2 mm
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treatment effects will be possible and allow assessment of
MCT over longer periods (as already successfully per-
formed in mice at the SPring-8 Synchrotron in Japan [22]).
Conclusion
This experiment demonstrated that the IMBL X-ray
beam is suitable for imaging MCT in ex vivo tissue sam-
ples from large animals. Our findings indicate that with
increased flux and reductions in exposure length the
measurement of MCT behaviour via PCXI imaging will
be possible in future live-imaging studies of intact large
animals such as sheep and pigs.
Appendix 1: Particle tracking algorithm
The MCT rate of the marker particles in each tracheal seg-
ment was determined using an automated analysis workflow
consisting of image pre-processing, background subtraction,
particle identification, particle tracking, and visualisation. All
were performed using custom software written in Matlab
(R2016b, The Mathworks, Natick, MA, USA).
A1. 1. Image pre-processing
Flat-field and dark-current correction were performed to
minimise the effects of dust and scratches on the scintil-
lator, and to minimise inhomogeneities in the X-ray
beam intensity.
A1. 2. Background subtraction
In the pig study there was too large a shift in the tissue
sample position as a result of the particle delivery
procedure for the background images acquired prior to
particle delivery to be useful for background subtraction.
Instead, we loaded ~60 equi-spaced images from the im-
aging run and extracted the maximum pixel value for
each pixel position through the stack to create a com-
posite image (See Additional file 4: Figure S1). This
process chose the brighter background over the dark
beads, and resulted in a background image that con-
tained no particles unless they were stationary for the
entire imaging run. Foreground images containing only
the moving particles were then created by subtracting
the background image from every image in the run.
A1. 3. Particle identification
To allow changes in particle behaviour in response to
treatment to be assessed over time, every 10-minute im-
aging block was split so that particle identification and
tracking was performed in ten 15-s blocks spaced 1 mi-
nute apart. Circular particles were identified in each
image in a block using the circular Hough transform.
True HRI marker particles were then selected based on
particle radius, with a range of 7.5 to 9.5 pixels (diameter
97 to 123 μm) empirically chosen to ensure the algo-
rithm identified most particles. The generous upper limit
allows for a small amount of motion blur that increases
the apparent diameter of the beads. The location of
every particle and the frame number in which it was
identified were stored in a Matlab data structure.
A1. 4. Particle tracking
Once every particle in each frame of a 15-s block was
identified, the particle locations were linked into trajector-
ies using a particle tracking algorithm developed by
Georgetown University [23]. Their algorithm examines
the positions of all n particles at time t(i), and the m
possible new positions at time t(i + 1), and considers all
possible combinations of the n old positions with the m
new positions, choosing the combination that results in
the minimal total squared displacement. In their algorithm
the trajectories are controlled by a displacement coeffi-
cient that represents the maximum distance a particle can
move between two frames. This parameter should be set
lower than the mean spacing between the particles, and
when it increases the run-time also increases significantly
due to the much larger number of possible tracking
combinations that must be evaluated. For this study the
maximum displacement parameter was set to 15 pixels
(~100 μm), which was the largest possible value that
allowed the tracking code to run for all the tracheal sam-
ples. The coordinates of the tracked particles and their
corresponding frame numbers were stored into a new data
structure. Particles that were tracked for less than four
consecutive frames were excluded.
The distance that each particle moved between frames
was calculated in pixels and converted to millimetres,
based on the size of the field of view. The MCT rate of
each particle was then calculated (in mm/min) based on
the time between analysis frames. The distance that every
tracked particle moved between every frame was reported
as the instantaneous particle MCT rate. All the instantan-
eous MCT rates for each particle were then averaged to
produce an average MCT rate for each particle, which was
reported as the average particle MCT rate.
A1. 5. Visualisation
The location of every tracked particle in each of the
analysed frames was marked (see Fig. 3). Particles for
which there was no reliable tracking data were not
marked, even if they were correctly identified by the
code described in Section A1.3.
Instantaneous tracking particle velocity histograms
were generated based on the magnitude and direction of
particle motion, and presented as a two dimensional
heat map [24]. Data was either separated and shown for
each imaging run (not shown), or data for each group
was pooled together and separated into time blocks
(Figs. 5 and 6).
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Additional files
Additional file 1: Video S1. Were assembled from the processed images
to show the variability in particulate behaviour on the tracheal airway
surfaces. The movie frame rate was set to 5x normal speed. Additional
file Videos can be played using the free VLC Media Player (available at
http://www.videolan.org/vlc/). shows MCT tracking particles in the
segment of sheep trachea shown in Fig. 3a, during a baseline (no
aerosol) run, taken from a dorsal/ventral view. The majority of particles
are correctly tracked, but occasional un-detected particles are visible.
(MP4 21840 kb)
Additional file 2: Video S2. Were assembled from the processed images
to show the variability in particulate behaviour on the tracheal airway
surfaces. The movie frame rate was set to 5x normal speed. Additional
file Videos can be played using the free VLC Media Player (available at
http://www.videolan.org/vlc/). shows tracked particles in a baseline run
from a dorsal/ventral view in the segment of pig trachea shown in
Fig. 3c. The direction of transport is clearly different to the sheep trachea.
(MP4 10903 kb)
Additional file 3: Video S3. Were assembled from the processed images
to show the variability in particulate behaviour on the tracheal airway
surfaces. The movie frame rate was set to 5x normal speed. Additional
file Videos can be played using the free VLC Media Player (available at
http://www.videolan.org/vlc/). shows MCT particle motion at the
segment of airway containing the pig carina, shown in Fig. 7. A number
of false positives were present in this run, due to bubbles on the airway
surface. (MP4 21962 kb)
Additional file 4: Figure S1. Example of the background subtraction
images. Example background subtraction images corresponding to
Fig. 3a and c, respectively. Scale bar 2 mm. (JPG 1321 kb)
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